Production (Stage)
Kairos Pharma, Ltd.
KAPA
$0.52
$0.0479.94%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.54M | -2.60M | -2.74M | -2.01M | -1.99M |
| Total Depreciation and Amortization | 160.00K | 160.00K | 160.00K | 160.00K | 160.00K |
| Total Amortization of Deferred Charges | 134.00K | 134.00K | 160.00K | 55.00K | 46.00K |
| Total Other Non-Cash Items | 394.00K | 338.00K | 1.50M | 933.00K | 933.00K |
| Change in Net Operating Assets | -1.85M | -1.98M | -1.17M | 883.00K | 975.00K |
| Cash from Operations | -4.71M | -3.96M | -2.09M | 25.00K | 125.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 142.00K | 142.00K | 142.00K | 102.00K | -- |
| Total Debt Repaid | -142.00K | -142.00K | -- | -- | -- |
| Issuance of Common Stock | 5.52M | 5.52M | 5.52M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.76M | -390.00K | -462.00K | -338.00K | -442.00K |
| Cash from Financing | 8.28M | 5.13M | 5.20M | -236.00K | -442.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.58M | 1.18M | 3.12M | -211.00K | -317.00K |